UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

A political battle continues within the U.S. government over renewing expired Affordable Care Act (ACA) subsidies. The ...

In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...

The new year should be a happier one for this beleaguered healthcare giant.

By Tatiana Bautzer NEW YORK, Nov 30 (Reuters) - UnitedHealth Group has agreed to sell its last South American business ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the ...

Discover why UnitedHealth Group (UNH) is rated Buy, with margin recovery, earnings growth, and 154% upside potential.

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media ...

UnitedHealth Group, the company that owns healthcare conglomerate UnitedHealth, said on Thursday that it is cooperating with the federal government as it fields criminal and civil requests from ...

UnitedHealth Group Inc. defeated an insurance reimbursement suit Tuesday after a federal appeals court affirmed the Employee ...

UnitedHealth Group Incorporated UNH, one of the nation’s leading healthcare plan providers, currently appears reasonably ...